These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 5382780)

  • 1. [Experience in the application of heparin electrophoresis in the treatment of patients with coronary sclerosis and angina pectoris].
    Glagoleva NA
    Vopr Kurortol Fizioter Lech Fiz Kult; 1969; 34(1):37-40. PubMed ID: 5382780
    [No Abstract]   [Full Text] [Related]  

  • 2. [Change in the coagulation and anticoagulation systems of the blood in patients with coronary cardiosclerosis with symptoms of stenocardia in treatment with heparin electrophoresis].
    Glagoleva NA; Shubina AV
    Ter Arkh; 1967 Sep; 39(9):88-93. PubMed ID: 5611710
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticoagulants updated--application in coronary artery disease.
    Robinson DS
    Cardiovasc Clin; 1974; 6(2):9-22. PubMed ID: 4613466
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of carbochromen in coronary insufficiency].
    Kobaladze SG; Saginjan VS; Sonija GS; Masasvili LS; Celisvili NV
    Arzneimittelforschung; 1970 Mar; 20():468-9. PubMed ID: 5468734
    [No Abstract]   [Full Text] [Related]  

  • 5. [Analgesic action of subcutaneous heparin therapy of stenocardia].
    Zeme D; Targetti M; Sassu G
    Clin Ter; 1972 Aug; 62(3):225-38. PubMed ID: 5081152
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of butadion on certain indices of hemostatic function in patients with coronary insufficiency].
    Kliachkin LM; Parshina ZS; Mit'kin AF
    Ter Arkh; 1969 Jan; 41(1):58-62. PubMed ID: 5377278
    [No Abstract]   [Full Text] [Related]  

  • 7. Blood coagulability and lipid metabolism in patients with coronary insufficiency.
    Panchenko VM; Bazaz'yan GG
    Fed Proc Transl Suppl; 1966; 25(5):800-2. PubMed ID: 5223562
    [No Abstract]   [Full Text] [Related]  

  • 8. [Influence of heparin electrophoresis on the functional state of the myocardium in patients with coronary atherosclerosis].
    Shustval' NF
    Vopr Kurortol Fizioter Lech Fiz Kult; 1975; (6):530-3. PubMed ID: 1229096
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of strophanthin on cardiovascular function and on tolerance of exercise in patients with angina pectoris treated with beta-adrenergic blocking].
    Volta G; Pavarani A; Barbaresi F; Starcich R
    G Clin Med; 1967 Oct; 48(10):1043-53. PubMed ID: 5605712
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes in the coagulation status of patients with chronic obstructive lung disease following the electrophoretic use of heparin].
    Marinov Kh; Petrova D; Raĭkova M; Kamenov V; Tikhova D
    Vutr Boles; 1988; 27(5):31-5. PubMed ID: 3213035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New therapeutic possibilities in the field of coronary disease].
    Pretolani E; Coccheri S; Zoli I; Baroncini S; Donato S; De Rosa V
    Clin Ter; 1975 Feb; 72(3):225-53. PubMed ID: 1132215
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of patients with ischemic heart diseases using senzit].
    Zamotaev IP; Venediktova MG; Zakharova GIu
    Klin Med (Mosk); 1988 Aug; 66(8):68-71. PubMed ID: 3193737
    [No Abstract]   [Full Text] [Related]  

  • 13. [The use of heparin and fibrinolysin in patients with coronary arteriosclerosis].
    Aleĭnikova LI
    Vrach Delo; 1966 Mar; 3():53-6. PubMed ID: 4230197
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effectiveness of small doses of heparin in ischemic heart disease].
    Doroshenko GL
    Vrach Delo; 1973 Nov; 11():27-30. PubMed ID: 4786926
    [No Abstract]   [Full Text] [Related]  

  • 15. [Anticoagulant properties of the electrophoresis of pyrazolone preparations in ischemic heart disease].
    Dizhenina II
    Vopr Kurortol Fizioter Lech Fiz Kult; 1983; (3):47-50. PubMed ID: 6623978
    [No Abstract]   [Full Text] [Related]  

  • 16. [Coronary dilatation after intracoronary administration of SIN-1 and intravenous molsidomine administration].
    Hug J; Hasenfuss G; Wollschläger H; Just HJ; Bonzel T
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():34-7. PubMed ID: 7968899
    [No Abstract]   [Full Text] [Related]  

  • 17. [Results of prolonged anticoagulant therapy of patients with coronary cardiosclerosis and angina pectoris].
    Kibarskis KhKh
    Klin Med (Mosk); 1966 Mar; 44(3):66-9. PubMed ID: 5993542
    [No Abstract]   [Full Text] [Related]  

  • 18. [A new drug for the therapy of angina pectoris and coronary insufficiency: Lidoflazine (R 7904)].
    Dziuba K
    Med Welt; 1967 Apr; 14():894-9. PubMed ID: 5585086
    [No Abstract]   [Full Text] [Related]  

  • 19. Observations made with Sensit in the treatment of angina pectoris patients.
    Keller L; Landi A
    Ther Hung; 1983; 31(4):176-80. PubMed ID: 6400457
    [No Abstract]   [Full Text] [Related]  

  • 20. [Lidocaine therapy of coronary ischemia and angina pectoris].
    Széplaki S; Szmandra J; Széplaki Z
    Munch Med Wochenschr; 1972 Nov; 114(45):1997-2002. PubMed ID: 4678452
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.